| Firm |
Analyst |
| Evercore ISI |
Cory Kasimov |
| Goldman Sachs & Company |
Paul Choi |
| Guggenheim Securities LLC |
Debjit Chattopadhyay, Ph.D. |
| HC Wainwright |
Joseph Pantginis, Ph.D. |
| J.P. Morgan Securities |
Tessa Romero |
| Piper Sandler & Co. |
Yasmeen Rahimi, Ph.D. |
| RBC Capital Markets |
Leonid Timashev, Ph.D. |
| Stifel |
James Condulis |
| SVB Leerink |
Joseph Schwartz |
| Truist Securities |
Srikripa Devarakonda, Ph.D. |
| Wedbush Securities |
Laura Chico, Ph.D. |
Edgewise Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Edgewise Therapeutics’ performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Edgewise Therapeutics or its management. Edgewise Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.